Drug information for LODOSYN

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
TABLET; ORAL	25MG	Prescription	(Reference Drug)	CARBIDOPA	Carbidopa	ATON	17830

Drug Adverse Effects information for LODOSYN

Role code	Indications	Reaction	# Reports
C	5Q MINUS SYNDROME	CONSTIPATION	1
C	5Q MINUS SYNDROME	HAEMOGLOBIN DECREASED	1
C	5Q MINUS SYNDROME	MENTAL STATUS CHANGES	1
C	5Q MINUS SYNDROME	URINARY RETENTION	1
C	OSTEOPOROSIS	COMPRESSION FRACTURE	1
C	OSTEOPOROSIS	FALL	1
C	OSTEOPOROSIS	INJECTION SITE EXTRAVASATION	1
C	OSTEOPOROSIS	INJECTION SITE HAEMATOMA	2
C	OSTEOPOROSIS	INJECTION SITE PRURITUS	1
C	OSTEOPOROSIS	LIGAMENT RUPTURE	1
C	OSTEOPOROSIS	PAIN	1
C	OSTEOPOROSIS	SWELLING	1
C	PARKINSON'S DISEASE	CONFUSIONAL STATE	3
C	PARKINSON'S DISEASE	CONSTIPATION	7
C	PARKINSON'S DISEASE	DRUG INTERACTION	3
C	PARKINSON'S DISEASE	HAEMOGLOBIN DECREASED	7
C	PARKINSON'S DISEASE	MEMORY IMPAIRMENT	3
C	PARKINSON'S DISEASE	MENTAL STATUS CHANGES	7
C	PARKINSON'S DISEASE	URINARY RETENTION	7

Ads by Google